Skip to content

Drug interactions

Armodafinil + Siponimod

Severity: Moderate

Armodafinil and Siponimod: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Armodafinil, a CYP3A4 inducer, may lower siponimod exposure and reduce its effect on multiple sclerosis. Labeling recommends avoiding moderate or strong CYP3A4 inducers in patients with certain CYP2C9 genotypes.

What this interaction means in plain words

Armodafinil and Siponimod can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Armodafinil belongs to Central Nervous System; Siponimod belongs to Central Nervous System.

Evidence level: Moderate

Why it happens

Armodafinil induces CYP3A4, increasing the clearance of siponimod, which is metabolized by CYP2C9 and CYP3A4.

What to do

Avoid the combination in CYP2C9*1/*3 and *2/*3 patients. Otherwise monitor for reduced disease control.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Armodafinil and Siponimod, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Armodafinil with Siponimod?

MediHelp rates the interaction as moderate. Armodafinil and Siponimod can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Armodafinil, a CYP3A4 inducer, may lower siponimod exposure and reduce its effect on multiple sclerosis. Labeling recommends avoiding moderate or strong CYP3A4 inducers in patients with certain CYP2C9 genotypes.

How serious is the interaction between Armodafinil and Siponimod?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination in CYP2C9*1/*3 and *2/*3 patients. Otherwise monitor for reduced disease control.

What other medicines interact with Armodafinil?

MediHelp also lists interactions of Armodafinil with, for example, Avapritinib, Elacestrant, Elbasvir / grazoprevir. The full list is on the Armodafinil page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in